162 related articles for article (PubMed ID: 27635619)
1. Knowledge of Clinical Trial Availability and Reasons for Nonparticipation Among Adolescent and Young Adult Cancer Patients: A Population-based Study.
Shnorhavorian M; Doody DR; Chen VW; Hamilton AS; Kato I; Cress RD; West M; Wu XC; Keegan THM; Harlan LC; Schwartz SM;
Am J Clin Oncol; 2018 Jun; 41(6):581-587. PubMed ID: 27635619
[TBL] [Abstract][Full Text] [Related]
2. Use of appropriate initial treatment among adolescents and young adults with cancer.
Potosky AL; Harlan LC; Albritton K; Cress RD; Friedman DL; Hamilton AS; Kato I; Keegan TH; Keel G; Schwartz SM; Seibel NL; Shnorhavorian M; West MM; Wu XC;
J Natl Cancer Inst; 2014 Nov; 106(11):. PubMed ID: 25301964
[TBL] [Abstract][Full Text] [Related]
3. An Age Stratified Analysis of the Access to Care Continuum Across Three Tumor Groups: Are There Delays for AYA?
Pettit T; Sue L; Waugh V; Ballantine K; Gardner K; Bremer L; Pemberton L; Allison L; Adams S; Chou E; Spearing R
J Adolesc Young Adult Oncol; 2019 Aug; 8(4):402-409. PubMed ID: 30912693
[No Abstract] [Full Text] [Related]
4. Increased clinical trial enrollment among adolescent and young adult cancer patients between 2006 and 2012-2013 in the United States.
Parsons HM; Penn DC; Li Q; Cress RD; Pollock BH; Malogolowkin MH; Wun T; Keegan THM
Pediatr Blood Cancer; 2019 Jan; 66(1):e27426. PubMed ID: 30256525
[TBL] [Abstract][Full Text] [Related]
5. Nonmetropolitan residence and other factors affecting clinical trial enrollment for adolescents and young adults with cancer in a US population-based study.
Mobley EM; Charlton ME; Ward MM; Lynch CF
Cancer; 2019 Jul; 125(13):2283-2290. PubMed ID: 30901085
[TBL] [Abstract][Full Text] [Related]
6. Adolescent and young adult enrollment to a National Cancer Institute-sponsored National Clinical Trials Network Research Group over 25 years.
Unger JM; Beauchemin M; Hershman DL
Cancer; 2021 Dec; 127(24):4574-4584. PubMed ID: 34351619
[TBL] [Abstract][Full Text] [Related]
7. Patient/Provider Discussions About Clinical Trial Participation and Reasons for Nonparticipation Among Adolescent and Young Adult Women with Cancer.
Anderson C; Smitherman AB; Meernik C; Edwards TP; Deal AM; Cannizzaro N; Baggett CD; Chao C; Nichols HB
J Adolesc Young Adult Oncol; 2020 Feb; 9(1):41-46. PubMed ID: 31545129
[No Abstract] [Full Text] [Related]
8. Clinical trial participation and time to treatment among adolescents and young adults with cancer: does age at diagnosis or insurance make a difference?
Parsons HM; Harlan LC; Seibel NL; Stevens JL; Keegan TH
J Clin Oncol; 2011 Oct; 29(30):4045-53. PubMed ID: 21931022
[TBL] [Abstract][Full Text] [Related]
9. Treatment-adjusted predisposition to second malignant neoplasms after a solid cancer in childhood: a case-control study.
Guérin S; Hawkins M; Shamsaldin A; Guibout C; Diallo I; Oberlin O; Brugières L; de Vathaire F
J Clin Oncol; 2007 Jul; 25(19):2833-9. PubMed ID: 17602088
[TBL] [Abstract][Full Text] [Related]
10. AYA Considerations for Aggressive Lymphomas.
Llaurador G; Giulino-Roth L
Curr Hematol Malig Rep; 2021 Feb; 16(1):61-71. PubMed ID: 33728589
[TBL] [Abstract][Full Text] [Related]
11. Survival differences between patients with Hodgkin lymphoma treated inside and outside clinical trials. A study based on the EORTC-Netherlands Cancer Registry linked data with 20 years of follow-up.
Liu L; Giusti F; Schaapveld M; Aleman B; Lugtenburg P; Meijnders P; Hutchings M; Lemmens V; Bogaerts J; Visser O
Br J Haematol; 2017 Jan; 176(1):65-75. PubMed ID: 27766636
[TBL] [Abstract][Full Text] [Related]
12. Risk of subsequent primary neoplasms in survivors of adolescent and young adult cancer (Teenage and Young Adult Cancer Survivor Study): a population-based, cohort study.
Bright CJ; Reulen RC; Winter DL; Stark DP; McCabe MG; Edgar AB; Frobisher C; Hawkins MM
Lancet Oncol; 2019 Apr; 20(4):531-545. PubMed ID: 30797674
[TBL] [Abstract][Full Text] [Related]
13. A population-based approach to compare patient-reported outcomes of long-term Hodgkin's lymphoma survivors according to trial participation: a joint study from the Patient-Reported Outcomes Following Initial Treatment and Long-term Evaluation of Survivorship registry and European Organisation for Research and Treatment of Cancer.
Thong MSY; Kicinski M; Coens C; Giusti F; van de Poll-Franse L; Bogaerts J; Liu L
Eur J Cancer Prev; 2017 Sep; 26 Joining forces for better cancer registration in Europe():S223-S228. PubMed ID: 28574866
[TBL] [Abstract][Full Text] [Related]
14. Adolescents and young adults with classical Hodgkin lymphoma in northern Tunisia: insights from an adult single-institutional study.
Zawati I; Adouni O; Finetti P; Manai M; Manai M; Gamoudi A; Birnbaum D; Bertucci F; Mezlini A
Cancer Radiother; 2020 Jun; 24(3):206-214. PubMed ID: 32171674
[TBL] [Abstract][Full Text] [Related]
15. Use of recommended posttreatment services for adolescent and young adult survivors of Hodgkin lymphoma.
Hahn EE; Wu YL; Munoz-Plaza CE; Garcia Delgadillo J; Cooper RM; Chao CR
Cancer; 2019 May; 125(9):1558-1567. PubMed ID: 30620388
[TBL] [Abstract][Full Text] [Related]
16. Inclusion of Patient-Reported Outcomes in Adolescent and Young Adult Phase III Therapeutic Trials: An Analysis of Cancer Clinical Trials Registered on ClinicalTrials.gov.
Berkman AM; Murphy KM; Siembida EJ; Lau N; Geng Y; Parsons SK; Salsman JM; Roth ME
Value Health; 2021 Dec; 24(12):1820-1827. PubMed ID: 34838280
[TBL] [Abstract][Full Text] [Related]
17. International development of four EORTC disease-specific quality of life questionnaires for patients with Hodgkin lymphoma, high- and low-grade non-Hodgkin lymphoma and chronic lymphocytic leukaemia.
van de Poll-Franse L; Oerlemans S; Bredart A; Kyriakou C; Sztankay M; Pallua S; Daniëls L; Creutzberg CL; Cocks K; Malak S; Caocci G; Molica S; Chie W; Efficace F;
Qual Life Res; 2018 Feb; 27(2):333-345. PubMed ID: 29127596
[TBL] [Abstract][Full Text] [Related]
18. Second cancer incidence and cause-specific mortality among 3104 patients with hairy cell leukemia: a population-based study.
Hisada M; Chen BE; Jaffe ES; Travis LB
J Natl Cancer Inst; 2007 Feb; 99(3):215-22. PubMed ID: 17284716
[TBL] [Abstract][Full Text] [Related]
19. Risk and outcome of non-Hodgkin lymphoma among classical Hodgkin lymphoma survivors.
Xavier AC; Armeson KE; Hill EG; Costa LJ
Cancer; 2013 Sep; 119(18):3385-92. PubMed ID: 23797978
[TBL] [Abstract][Full Text] [Related]
20. [Association over time of Hodgkin lymphoma and non-Hodgkin lymphoma: study of 6 patients in one single center].
Pérez-Montaña A; Sancho JM; Mate JL; Ribera JM
Med Clin (Barc); 2012 Dec; 139(15):695-6. PubMed ID: 22809967
[No Abstract] [Full Text] [Related]
[Next] [New Search]
